A detailed history of Two Sigma Investments, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 381,242 shares of BBIO stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
381,242
Previous 565,452 32.58%
Holding current value
$10.9 Million
Previous $14.3 Million 32.23%
% of portfolio
0.02%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $4.4 Million - $5.77 Million
-184,210 Reduced 32.58%
381,242 $9.71 Million
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $4.12 Million - $5.56 Million
-179,148 Reduced 24.06%
565,452 $14.3 Million
Q1 2024

May 15, 2024

SELL
$27.35 - $40.45 $6.08 Million - $8.99 Million
-222,197 Reduced 22.98%
744,600 $23 Million
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $7.45 Million - $13.6 Million
-310,287 Reduced 24.3%
966,797 $39 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $9.06 Million - $18.8 Million
536,693 Added 72.49%
1,277,084 $33.7 Million
Q2 2023

Aug 14, 2023

SELL
$13.29 - $18.01 $520,290 - $705,073
-39,149 Reduced 5.02%
740,391 $12.7 Million
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $920,118 - $2.38 Million
128,329 Added 19.71%
779,540 $12.9 Million
Q4 2022

Feb 14, 2023

SELL
$6.74 - $11.52 $1.48 Million - $2.53 Million
-219,996 Reduced 25.25%
651,211 $4.96 Million
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $5.72 Million - $8.9 Million
719,944 Added 475.96%
871,207 $8.66 Million
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $1.87 Million - $4.35 Million
-358,285 Reduced 70.31%
151,263 $1.37 Million
Q1 2022

May 16, 2022

SELL
$7.34 - $17.16 $709,344 - $1.66 Million
-96,641 Reduced 15.94%
509,548 $5.17 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $6.37 Million - $29.9 Million
559,467 Added 1197.44%
606,189 $10.1 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $1.45 Million - $1.99 Million
31,043 Added 197.99%
46,722 $2.19 Million
Q2 2021

Aug 16, 2021

SELL
$46.47 - $63.93 $21.8 Million - $29.9 Million
-468,149 Reduced 96.76%
15,679 $956,000
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $17.7 Million - $23.1 Million
319,239 Added 193.96%
483,828 $29.8 Million
Q4 2020

Feb 16, 2021

BUY
$38.38 - $71.11 $1.24 Million - $2.3 Million
32,414 Added 24.52%
164,589 $11.7 Million
Q3 2020

Nov 16, 2020

BUY
$27.2 - $42.19 $3.6 Million - $5.58 Million
132,175 New
132,175 $4.96 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.